Preoperative dexmedetomidine attenuates hemodynamic responses to hydrodissection in patients undergoing robotic thyroidectomy
详细信息    查看全文
文摘
Purpose Percutaneous tunneling (hydrodissection) in the neck and anterior chest in patients undergoing robotic thyroidectomy leads to significant hemodynamic responses such as increases in blood pressure and heart rate. We evaluated whether a single preoperative dexmedetomidine injection attenuated hemodynamic responses to hydrodissection by reducing the half-maximal effective concentration (EC50) of remifentanil needed to maintain hemodynamic stability during hydrodissection. Methods Forty-one patients undergoing robot-assisted endoscopic thyroidectomy were randomly allocated to one of the two groups—group D (n?=?22) and group C (n?=?19) patients received dexmedetomidine 1?μg/kg and normal saline for 10?min before anesthetic induction, respectively. The EC50 of remifentanil for hemodynamic stability during hydrodissection was determined using Dixon’s up-and-down method with initial dose (4?and 5?ng/mL in groups D and C, respectively). The concentration of remifentanil for consecutive patients in each group was determined by the response of the previous patient, using increments or decrements of 0.5?ng/mL. Hemodynamic stability during hydrodissection was defined as increased systolic blood pressure Results The EC50 of remifentanil for maintaining hemodynamic stability during hydrodissection was 0.8?ng/mL in group D and 7.3?ng/mL in group C (p?=?0.002). Conclusions A single preoperative dexmedetomidine injection attenuated hydrodissection-induced hemodynamic responses in patients undergoing robotic thyroidectomy.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700